Sai Life Sciences Limited (NSE:SAILIFE)

Market Cap	153.70B
Revenue (ttm)	16.95B
Net Income (ttm)	1.70B
Shares Out	208.49M
EPS (ttm)	8.61
PE Ratio	85.62
Forward PE	65.03
Dividend	n/a
Ex-Dividend Date	n/a

Volume	107,282
Average Volume	623,574
Open	736.50
Previous Close	731.50
Day's Range	728.40 - 739.15
52-Week Range	636.10 - 808.80
Beta	n/a
RSI	52.90
Earnings Date	May 14, 2025

About Sai Life Sciences

Sai Life Sciences Limited operates as a contract research, development, and manufacturing organization (CRDMO) in India and internationally. The company offers medicinal chemistry, pharmacokinetics, manufacturing, and contract development services. The company was formerly known as SAI Advantium Pharma Limited and changed its name to Sai Life Sciences Limited in July 2006. Sai Life Sciences Limited was incorporated in 1999 and is based in Hyderabad, India.

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1999
• Employees: 2,845
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: SAILIFE

Financial Performance

In 2024, Sai Life Sciences's revenue was 16.95 billion, an increase of 15.66% compared to the previous year's 14.65 billion. Earnings were 1.70 billion, an increase of 105.45%.